7-Ketocholesterol upregulates interleukin-6 via mechanisms that are distinct from those of tumor necrosis factor-α, in vascular smooth muscle cells

Journal of Vascular Research

Volumn 46, Issue 1, 2008, Pages 36-44

  Sung, Si Chan ^a   Kim, Koanhoi ^a   Lee, Kyeong Ah ^a   Choi, Kyung Ha ^a   Kim, Sun Mi ^a   Son, Yong Hae ^a   Moon, Yu Seok ^a   Eo, Seong Kug ^b   Rhim, Byung Yong ^a  

^a Pusan National University School of Medicine   (South Korea)

^b Chonbuk National University   (South Korea)

Author keywords

7 Ketocholesterol; Interleukin 6; Tumor necrosis factor; Vascular smooth muscle cell

Indexed keywords

26 HYDROXYCHOLESTEROL; 7 OXOCHOLESTEROL; BREFELDIN A; CHOLESTEROL; HUR PROTEIN; INTERLEUKIN 6; JANUS KINASE INHIBITOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; OXYSTEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; AORTA; AORTA MEDIA; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RNA DEGRADATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTHRACENES; BREFELDIN A; CCAAT-ENHANCER-BINDING PROTEINS; CELLS, CULTURED; DACTINOMYCIN; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; IMIDAZOLES; INTERLEUKIN-6; KETOCHOLESTEROLS; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; PYRIDINES; RATS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 57449118767     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000135663     Document Type: Article

References (30)

1. Brown AJ, Jessup W: Oxysterols and atherosclerosis. Atherosclerosis 1999;142:1-28.
2. Garcia-Cruset S, Carpenter KL, Guardiola F, Stein BK, Mitchinson MJ: Oxysterol profiles of normal human arteries, fatty streaks and advanced lesions. Free Radic Res 2001;35:31-41.
3. Vaya J, Aviram M, Mahmood S, Hayek T, Grenadir E, Hoffman A, Milo S: Selective distribution of oxysterols in atherosclerotic lesions and human plasma lipoproteins. Free Radic Res 2001;34:485-497.
4. Olkkonen VM, Lehto M: Oxysterols and oxysterol binding proteins: role in lipid metabolism and atherosclerosis. Ann Med 2004;36:562-572.
5. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi AG, Ciliberto G, Maseri A: Elevated levels of interleukin-6 in unstable angina. Circulation 1996;94:874-877.
6. Hojo Y, Ikeda U, Katsuki T, Mizuno O, Fukazawa H, Kurosaki K, Fujikawa H, Shimada K: Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis. Heart 2000;84:83-87.
7. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 2002;105:1135-1143.
8. Schieffer B, Selle T, Hilfiker A, Hilfiker-Kleiner D, Grote K, Tietge UJ, Trautwein C, Luchtefeld M, Schmittkamp C, Heeneman S, Daemen MJ, Drexler H: Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. Circulation 2004;110:3493-3500.
9. Jatta K, Wagsater D, Norgren L, Stenberg B, Sirsjo A: Lipopolysaccharide-induced cytokine and chemokine expression in human carotid lesions. J Vasc Res 2005;42:266-271.
10. Rus HG, Vlaicu R, Niculescu F: Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 1996;127:263-271.
11. Rho MC, Kim YK, Chang JS, Lee HS, Baek JA, Chung MY, Lee HC, Lee HW, Rhim BY, Reidy MA, Kim K:7-ketocholesterol predisposes human aorta smooth muscle cells to fas-mediated death. J Mol Cell Cardiol 2005;39:823-832.
12. Eickelberg O, Roth M, Mussmann R, Rudiger JJ, Tamm M, Perruchoud AP, Block LH: Calcium channel blockers activate the interleukin-6 gene via the transcription factors NF-IL6 and NF-κB in primary human vascular smooth muscle cells. Circulation 1999;99:2276-2282.
13. Wang JS, Zhang F, Jiang M, Wang MH, Zand BA, Abraham NG, Nasjletti A, Laniado-Schwartzman M: Transfection and functional expression of CYP4A1 and CYP4A2 using bicistronic vectors in vascular cells and tissues. J Pharmacol Exp Ther 2004;311:913-920.
14. Atasoy U, Watson J, Patel D, Keene JD: ELAV protein HuA (HuR) can redistribute between nucleus and cytoplasm and is upregulated during serum stimulation and T cell activation. J Cell Sci 1998;111:3145-3156.
15. Keene JD: Why is Hu where? Shuttling of early-response-gene messenger RNA subsets. Proc Natl Acad Sci USA 1999;96:5-7.
16. Berthier A, Lemaire-Ewing S, Prunet C, Montange T, Vejux A, Pais de Barros JP, Monier S, Gambert P, Lizard G, Neel D:7-ketocholesterol-induced apoptosis. Involvement of several pro-apoptotic but also antiapoptotic calcium-dependent transduction pathways. FEBS J 2005;272:3093-3104.
17. Lizard G, Monier S, Cordelet C, Gesquiere L, Deckert V, Gueldry S, Lagrost L, Gambert P: Characterization and comparison of the mode of cell death, apoptosis versus necrosis, induced by 7β-hydroxycholesterol and 7-ketocholesterol in the cells of the vascular wall. Arterioscler Thromb Vasc Biol 1999;19:1190-1200.
18. Martinet W, De Bie M, Schrijvers DM, De Meyer GR, Herman AG, Kockx MM: 7-ketocholesterol induces protein ubiquitination, myelin figure formation, and light chain 3 processing in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2004;24:2296-2301.
19. Miguet-Alfonsi C, Prunet C, Monier S, Bessede G, Lemaire-Ewing S, Berthier A, Menetrier F, Neel D, Gambert P, Lizard G: Analysis of oxidative processes and of myelin figures formation before and after the loss of mitochondrial transmembrane potential during 7β-hydroxycholesterol and 7-ketocholesterol-induced apoptosis: comparison with various pro-apoptotic chemicals. Biochem Pharmacol 2002;64:527-541.
20. Seye CI, Knaapen MW, Daret D, Desgranges C, Herman AG, Kockx MM, Bult H: 7-ketocholesterol induces reversible cytochrome c release in smooth muscle cells in absence of mitochondrial swelling. Cardiovasc Res 2004;64:144-153.
21. Lemaire-Ewing S, Prunet C, Montange T, Vejux A, Berthier A, Bessede G, Corcos L, Gambert P, Neel D, Lizard G: Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols. Cell Biol Toxicol 2005;21:97-114.
22. Erridge C, Webb DJ, Spickett CM: 25-hydroxycholesterol, 7β-hydroxycholesterol and 7-ketocholesterol upregulate interleukin-8 expression independently of Toll-like receptor 1, 2, 4 or 6 signalling in human macrophages. Free Radic Res 2007;41:260-266.
23. Schroepfer GJ, Jr.: Oxysterols: Modulators of cholesterol metabolism and other processes. Physiol Rev 2000;80:361-554.
24. Sevanian A, Bittolo-Bon G, Cazzolato G, Hodis H, Hwang J, Zamburlini A, Maiorino M, Ursini F: LDL- is a lipid hydroperoxide-enriched circulating lipoprotein. J Lipid Res 1997;38:419-428.
25. Ammit AJ, Lazaar AL, Irani C, O'Neill GM, Gordon ND, Amrani Y, Penn RB, Panettieri RA, Jr: Tumor necrosis factor-α-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and β-agonists. Am J Respir Cell Mol Biol 2002;26:465-474.
26. Baccam M, Woo SY, Vinson C, Bishop GA: CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes: involvement of NF-κB, AP-1, and C/EBP. J Immunol 2003;170:3099-3108.
27. Wang Z, Castresana MR, Newman WH: NF-κB is required for TNF-α-directed smooth muscle cell migration. FEBS Lett 2001;508:360-364.
28. Xu N, Chen CY, Shyu AB: Modulation of the fate of cytoplasmic mRNA by AU-rich elements: key sequence features controlling mRNA deadenylation and decay. Mol Cell Biol 1997;17:4611-4621.
29. Winzen R, Kracht M, Ritter B, Wilhelm A, Chen CY, Shyu AB, Muller M, Gaestel M, Resch K, Holtmann H: The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via map kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J 1999;18:4969-4980.
30. Ikeda U, Ito T, Shimada K: Interleukin-6 and acute coronary syndrome. Clin Cardiol 2001;24:701-704.